Why the study?
Prediction tools are increasingly used to estimate prognosis and personalize decision-making in soft-tissue sarcoma of the extremities, prompting an overview of available tools and practical guidance for clinicians.
This annotation provides an overview of available prediction tools for soft-tissue sarcomas of the extremity to facilitate personalized clinical decision-making.
Answers are grounded in this paper and cite their sources.
May aid personalized prognostication in eSTS; leaves open optimal model selection pending external validation.
Prediction tools are instruments which are commonly used to estimate the prognosis in oncology and facilitate clinical decision-making in a more personalized manner. Their popularity is shown by the increasing numbers of prediction tools, which have been described in the medical literature. Many of these tools have been shown to be useful in the field of soft-tissue sarcoma of the extremities (eSTS). In this annotation, we aim to provide an overview of the available prediction tools for eSTS, provide an approach for clinicians to evaluate the performance and usefulness of the available tools for their own patients, and discuss their possible applications in the management of patients with an eSTS. Cite this article: Bone Joint J 2022;104-B(9):1011–1016.
No takes yet. Share an insight, caveat, or question.
Acem et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: